Tapinarof Under FDA Review for Treating Atopic Dermatitis

Approved in 2022 for psoriasis, the manufacturer has submitted an application for approval of tapinarof cream for treating atopic dermatitis in adults and children 2 years of age and older.

Related Keywords

,Drug Administration ,Dermavant Sciences ,New Drug Application ,Validated Investigator Global Assessment ,Atopic Dermatitis ,Dermatitis ,Atopic Eczema ,Children ,Child ,Childhood ,Ediatrics ,Kids ,Psoriasis ,Otolaryngology ,Nt Specialty ,Ead And Neck Surgery Ent Speciality ,Contact Dermatitis ,Folliculitis ,Common Cold ,Cute Nasopharyngitis ,Plaque Psoriasis ,Pruritus ,Pruritis ,Pitch ,Receptors ,Headache ,Skin And Soft Tissue Infection ,